CoChat

Exploration of databases and methods supporting drug repurposing: a comprehensive survey

Open access

The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.

Abstract

Drug development involves a deep understanding of the mechanisms of action and possible side effects of each drug, and sometimes results in the identification of new and unexpected uses for drugs, termed as drug repurposing. Both in case of serendipitous observations and systematic mechanistic explorations, confirmation of new indications for a drug requires hypothesis building around relevant drug-related data, such as molecular targets involved, and patient and cellular responses. These datasets are available in public repositories, but apart from sifting through the sheer amount of data imposing computational bottleneck, a major challenge is the difficulty in selecting which databases to use from an increasingly large number of available databases. The database selection is made harder by the lack of an overview of the types of data offered in each database. In order to alleviate these problems and to guide the end user through the drug repurposing efforts, we provide here a survey of 102 of the most promising and drug-relevant databases reported to date. We summarize the target coverage and types of data available in each database and provide several examples of how multi-database exploration can facilitate drug repurposing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/bib/bbaa003

Cites

167 of 167 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Drug repositioning databases categorized into more than one subcategory. Some subcategories are shown more than once in order to facilitate the interpretation of database relationships.
Figure 1 Drug repositioning databases categorized into more than one subcategory. Some subcategories are shown more than once in order to facilitate the interpretation of database relationships.CC BY-NC · PubMed Central
Figure 2 Disease-based drug repurposing workflow using databases listed in Tables 1–4. Databases are mentioned inside brackets. Dark font shows recommended databases and normal font shows alternative databases. The workflow describes steps for disease-based computational drug repurposing for AML; however, the same sequence of steps and the listed databases can be used for other diseases.
Figure 2 Disease-based drug repurposing workflow using databases listed in Tables 1–4. Databases are mentioned inside brackets. Dark font shows recommended databases and normal font shows alternative databases. The workflow describes steps for disease-based computational drug repurposing for AML; however, the same sequence of steps and the listed databases can be used for other diseases.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Lotfi Shahreza, 2018, A review of network-based approaches to drug repositioning, Brief Bioinform, 19, 878, 10.1093/bib/bbx017 · DOI · Paper page

Cited by

See all 133

Metadata

Authors
Tanoli, Z., Seemab, U., Scherer, A., Wennerberg, K., Tang, J., & Vähä-Koskela, M.
Affiliations
  • University of Helsinki (FI)
  • University of Copenhagen (DK)
Corresponding author
  • Tanoli, Ziaurrehman
  • Tang, Jing
  • Vähä-Koskela, Markus
Venue
Briefings in Bioinformatics
Published
2020-02-14
Volume
22
Issue
2
Pages
1656-1678
ISSN
  • 1467-5463 (ISSN-L)
  • 1477-4054
OpenAlex
W3006508031
Cited by
131
References
167
Citations by year
2026: 9 · 2025: 23 · 2024: 22 · 2023: 25 · 2022: 25 · 2021: 17 · 2020: 10
FWCI
1.72
Type
journal article
Language
en
Open access
Locations
  • Briefings in Bioinformatics (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
  • Työväentutkimus Vuosikirja (submittedVersion)
Funders
  • European Research Council (716063)
  • Academy of Finland (317680)
  • European Commission (824087)
  • Medicinska Understödsföreningen Liv och Hälsa
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
Keywords
drug repurposing, drug databases, database selection, molecular targets, drug mechanisms of action, adverse drug reactions, drug discovery
MeSH terms
Surveys and Questionnaires, Databases, Factual, Drug Delivery Systems, Computational Biology, Drug Repositioning

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.